SFSurasak Faisatjatham

Surasak Faisatjatham

*This is an algorithmically generated author record based on publicly available information.

Surasak Faisatjatham has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Associations between hypochloremia with in-hospital mortality and vasopressor dependence in patients with septic shock requiring vasopressors

    by Surasak Faisatjatham, Yolardee Khankhonchim

    Background: Hypochloremia is common and has been linked to increased mortality among critically ill patients. However, the pathophysiological role of hypochloremia is insufficiently explored. This study aimed to assess the associations between hypochloremia with in-hospital mortality and vasopressor dependence among patients with septic shock. Method: A retrospective cohort study was conducted at Khon Kaen Hospital. Patients with septic shock requiring vasopressors were included from July to December 2022 and categorized into three groups based on serum chloride levels prior to vasopressor initiation (up to 72 hours before septic shock diagnosis): hypochloremia (105 mEq/L). The primary outcome was a comparison of in-hospital mortality between patients with hypochloremia and normochloremia. Secondary outcomes include vasopressor duration and vasopressor dependence or death at 24, 48, and 72 hours. Result: Of the 420 patients included, 35.7% were hypochloremic and 52.4% were normochloremic based on baseline serum chloride status. In-hospital mortality was higher in patients with hypochloremia compared with normochloremia (48.7% vs 37.3%; P=0.044). In multivariable analysis (N=373), after adjustment for age, sex, infection source, bacteremia, fluid balance, and baseline bicarbonate status, hypochloremia remained associated with increased mortality (adjusted RR 1.48, 95% CI 1.13-1.96; P=0.005). No significant differences were found in vasopressor duration or vasopressor dependence or death at 24, 48, and 72 hours among the 3 groups. Conclusion: Hypochloremia was associated with increased in-hospital mortality after multivariable adjustment in patients with septic shock. However, an association between hypochloremia and vasopressor dependence or duration was not demonstrated. Other adverse outcomes of hypochloremia leading to excess mortality should be further explored.

  • Open Access

    Regional Variation of Aetiologies and Complications in Chronic Kidney Disease From Thailand ( THAI ‐ CKD Registry)

    by Kavita Jintanapramote, Thatsaphan Srithongkul, Thananda Trakarnvanich, Juthamash Sangsuk, Sirirat Asawamethapant, Jathurong Kittrakulrat, Tossaporn Sapsitthikul, Kajohnsak Noppakun, Narittaya Varothai, Sirirat Anutrakulchai, et al.

    Aim: To investigate regional variations in Chronic Kidney Disease (CKD) aetiologies and complications across KDIGO risk strata in Thailand, aiming to optimise screening and monitoring in resource‐constrained settings. Methods: Baseline data from the multicentre THAI‐CKD cohort of adults with stages G3‐G5 CKD from 41 hospitals were analysed. Demographic, clinical and laboratory data were collected. Causes of kidney disease, including chronic kidney disease of unknown aetiology (CKDu) and metabolic complications were examined across KDIGO glomerular filtration rate and albuminuria (G‐A) categories, primary aetiologies, and geographic regions. Results: Among 3371 participants (mean age: 69 ± 12 years; 55% male), stage distribution was G3a 20%, G3b 33%, G4 37% and G5 10%. Diabetic nephropathy (41%) and hypertensive nephrosclerosis (34%) were the most common causes, whereas CKDu accounted for 22% overall and was concentrated in earlier stages with lower albuminuria and in the Central (33%) and Western (24%) regions. Complications showed clear gradients across G‐A strata: anaemia and metabolic acidosis increased with lower estimated glomerular filtration rate and higher albuminuria. Secondary hyperparathyroidism occurred across all stages and was most frequent in G5, whereas hyperphosphatemia was mainly observed in G5 and hyperkalaemia remained rare across all categories. The prevalence of complications also varied by primary aetiology and geographic region, and these associations remained significant after multivariable adjustment. Conclusion: This national cohort demonstrated pronounced regional and etiologic heterogeneity in CKD and revealed stage‐ and albuminuria‐dependent patterns of metabolic complications. These findings support the use of KDIGO G‐A staging and regional profiles to prioritise etiologic evaluation and tailor laboratory monitoring in low‐ and middle‐income settings.


  • Open Access

    Kidney replacement therapy and mortality in metformin-associated lactic acidosis with acute kidney injury (2015–2021): a multi-year cohort study

    by Sarassawan Kananuruks, Ekthanat Akkarakanoksin, Thanachai Panaput, Surasak Faisatjatham, Suphanan Phisalwut, Arkom Nongnuch

    Metformin-associated lactic acidosis (MALA) is a life-threatening complication. Treatment of MALA includes supportive care and dialysis. However, the role of kidney replacement therapy (KRT) in MALA is controversial, this study aimed to compare patient and kidney outcomes between MALA-acute kidney injury (AKI) patients receiving KRT (KRT group) vs. supportive care (supportive care group). A cohort study was conducted on 143 adult patients with MALA-AKI from 1 January 2015 to 31 December 2021. The primary outcome was the patient mortality rate and predictive factors of mortality, while the secondary outcomes were kidney survival. The overall mortality rate in our MALA-AKI cohort was 20.3% (29 of 143 patients). The KRT group had a lower mortality rate compared with the supportive care group (16% vs. 28.6%, P = 0.006). Among patients who received dialysis, hemodialysis (HD) was associated with a lower mortality rate compared with acute peritoneal dialysis (APD) (8.9% vs. 30.8%, P = 0.044). Patients who received late KRT (≥6 h) had a trend toward higher mortality compared with those who received early KRT (P = 0.002), prolonged prothrombin time (HR 1.20, P = 0.001) and higher Sequential Organ Failure Assessment (SOFA) scores (HR 1.26, P = 0.006). MALA-AKI was associated with high mortality, and KRT reduced mortality rate when compared with supportive care. HD was the most effective treatment in MALA-AKI, early KRT initiation (<6 h) showed a trend toward lower mortality and oliguria, prolonged prothrombin time, and higher SOFA scores were identified as prognostic markers.